The real AI opportunity in clinical trials isn’t efficiency – it’s simulating better studies before enrollment begins.
- Why Are Life Science Companies So Poorly Prepared For RIM's Future?
- Digital Endpoints Are Ready. Clinical Development Isn't
- Why Clinical Trial Data Cleaning Must Go Continuous (And How To Do It)
- What Clinical Analytics Solutions Are Shaping Clinical Research
- Sites Are Building Their Own Tech – SCRS On What That Means
- Human-In-The-Loop In AI Validation And Control: From Principle To Practice
- When The System Breaks, Who Pays? SCRS On Site Tech Gaps
- HTA, Digital Twins, And Building Clinical Tech That Lasts
ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
Why Native Apps Trump Web Apps For Security And Performance
Explore the advantages of native applications in clinical research, including better performance, user experience, security, and integration capabilities.
-
Building Patient-Focused eCOA Strategies: Insights And Best Practices
Discover why the use of electronic clinical outcome assessments (eCOA) in clinical research is becoming an increasingly important part of study design in this article.
-
Benefits Of Delegating Your Oncology Trials Patient Screening Process
Explore the integration of Electronic Health Records (EHR) into oncology clinical trials, highlighting both challenges and potential advancements.
-
How To Make eConsent Accessible Across Diverse Populations
Accessible eConsent removes language, literacy, disability, and tech barriers, improving comprehension, equity, compliance, participant trust, inclusive enrollment, and data quality.
-
How To Prepare An IRB Submission For A Remote eConsent Study
IRBs are increasingly supportive of eConsent solution. Even so, researchers may find themselves in need of guidance as they prepare for an eConsent IRB review.
-
Demystifying AI In Clinical Trials
AI is revolutionizing clinical trials by improving efficiency and data quality, but success depends on strategy and oversight. Explore practical ways to integrate AI responsibly.
-
Execution Intelligence: Get A Competitive Advantage In Clinical Trials
AI fails in clinical trials when decision-making is messy. To win, sponsors must fix their "execution blind spot" by structuring how work happens, letting AI turn hidden patterns into strategy.
-
The Power Of A Collaboration Platform
Using a recent Phase III Endocrinology trial as a primary case study, this article illustrates the qualitative shift from administrative burden to strategic oversight.
-
Creating Success With Digital Measures
Recent research from the Tufts Center for the Study of Drug Development (CSDD) illuminated the substantial ROI of digital endpoints in clinical trials. Discover how to transform your trials today.
-
How Long Is Your RTSM Risk Mitigation List?
While RTSM systems help reduce many of the risks in clinical trials, each trial’s unique setup necessitates a risk analysis to identify trial-specific challenges.
- How AI Is Changing Clinical Trial Design, Not Just Speed
- What Is Clinical Trials Day? Why Technology Helps Research Rise
- DiMe's Navigator: Why Teams Still Stall On Digital Endpoints
- Digital Endpoints Are Ready. Clinical Development Isn't
- Why Clinical Trial Data Cleaning Must Go Continuous (And How To Do It)
RECENT NEWSLETTERS
- 05.14.26 -- AI, RWE, And The Systems Breaking Clinical Trials
- 05.07.26 -- How AI, ICH E6(R3) & RWD Are Reshaping Clinical Trials
- 05.02.26 -- Best Of April: AI In Clinical Trials — What Working
- 04.30.26 -- AI, RWE & Predictive Analytics Are Reshaping Trials
- 04.23.26 -- Smarter Trials Start Here: Data Quality, AI & Infrastructure Insights